OpenAlex
PricingAboutJobs
Log inGet started
Author

Anna Miserocchi

Observed names: A. Miserocchi, Miserocchi, Anna
Institution: Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori
Observed institution: Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori
ORCID: 0000-0003-1087-9146
Observed ORCID: 0000-0003-1087-9146
OpenAlex ID: A5137097071
Post-VABB Cavity-Targeted Avidin-Pretargeted [90Y]Y-DOTA-Biotin in Nonpalpable Breast Cancer: A Phase I Activity-Escalation Study (ARTHE)
2026 · Maddalena Sansovini, Paola Sanna, et al. · Cancers
Combining immune checkpoint inhibition and dendritic cell vaccination in advanced pleural and peritoneal mesothelioma: The phase 1b MESOVAX trial.
2026 · Laura Ridolfi, Angelo Delmonte, et al. · Journal of Clinical Oncology
122eTiP CombiCoR-Vax trial: Study protocol for a phase II, single-arm, multicenter trial of sequential pembrolizumab plus dendritic cell vaccine followed by trifluridine/tipiracil and bevacizumab in refractory microsatellite-stable metastatic colorectal cancer
2025 · F.G. Sullo, A. Passardi, et al. · Immuno-Oncology Technology
Works count: 5
Citation count:
H-index:
I10-index:
Year
Topic
Type
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms